“Ultimately, I think there are subtle, but real, differences between Moderna and Pfizer,” said Jeffrey Wilson, an immunologist and physician at the University of Virginia in Charlottesville who co-authored one of those studies, published in JAMA Network Open this month. “In high-risk populations, it could be relevant. It would be good if people analyze it carefully ”.
–
